A Safety Study of SGN-CD48A in Patients With Multiple Myeloma

NCT03379584 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
14
Enrollment
INDUSTRY
Sponsor class

Stopped Due to overall benefit/risk profile

Conditions

Interventions

Sponsor

Seagen Inc.